Emerald Mutual Fund Advisers Trust’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-824,402
| Closed | -$13M | – | 249 |
|
|
2024
Q1 | $13M | Buy |
824,402
+298,131
| +57% | +$4.59M | 0.68% | 61 |
|
|
2023
Q4 | $8.49M | Buy |
+526,271
| New | +$6.71M | 0.45% | 89 |
|
|
2021
Q2 | – | Sell |
-319,202
| Closed | -$14.3M | – | 241 |
|
|
2021
Q1 | $14.3M | Hold |
319,202
| – | – | 0.48% | 89 |
|
|
2020
Q4 | $18.2M | Buy |
319,202
+71,454
| +29% | +$4.24M | 0.63% | 66 |
|
|
2020
Q3 | $12.7M | Buy |
247,748
+57,266
| +30% | +$2.81M | 0.56% | 70 |
|
|
2020
Q2 | $11.4M | Buy |
190,482
+93,050
| +96% | +$4.98M | 0.54% | 66 |
|
|
2020
Q1 | $4.01M | Buy |
+97,432
| New | +$5.41M | 0.25% | 109 |
|
|
2019
Q3 | – | Sell |
-364,105
| Closed | -$8.21M | – | 219 |
|
|
2019
Q2 | $8.21M | Hold |
364,105
| – | – | 0.33% | 109 |
|
|
2019
Q1 | $8.45M | Sell |
364,105
-249,176
| -41% | -$6.52M | 0.34% | 108 |
|
|
2018
Q4 | $12.9M | Sell |
613,281
-53,981
| -8% | -$1.33M | 0.6% | 57 |
|
|
2018
Q3 | $25.8M | Buy |
667,262
+155,082
| +30% | +$5.73M | 0.87% | 28 |
|
|
2018
Q2 | $20.2M | Buy |
512,180
+79,120
| +18% | +$2.33M | 0.73% | 42 |
|
|
2018
Q1 | $8.68M | Buy |
433,060
+16,718
| +4% | +$423K | 0.34% | 112 |
|
|
2017
Q4 | $9.44M | Buy |
416,342
+124,195
| +43% | +$2.43M | 0.38% | 98 |
|
|
2017
Q3 | $5.55M | Buy |
+292,147
| New | +$5.35M | 0.23% | 138 |
|
Other funds holding DCPH
Emerald Mutual Fund Advisers Trust's DCPH Position: Q2 2024 in Review
Emerald Mutual Fund Advisers Trust sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 824,402 shares — an estimated $13M sold.
Emerald Mutual Fund Advisers Trust first reported a position in DCPH in Q3 2017 and held it in 15 quarters. The position peaked at $25.8M in Q3 2018. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Emerald Mutual Fund Advisers Trust reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Emerald Mutual Fund Advisers Trust sold 824,402 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $13M.
- Emerald Mutual Fund Advisers Trust first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 15 quarters.
- Emerald Mutual Fund Advisers Trust's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $25.8M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2024, filed 6 Aug 2024.